Project Grant W81XWH2210235
Award Date
8/1/22
Completion Date
7/31/25
Dollars Obligated
$2M
Federal Agency
Medical Command
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Monmouth Junction, South Brunswick Township, NJ 08852, USA
Similar Awards
This $8,042,749 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) is funding research at The Ohio State University to enhance the safety and efficacy of low-titer Group O whole blood. The research involves determining optimal concentrations of hemopexin, haptoglobin, and transferrin to neutralize hemolytic byproducts during ex vivo storage of whole blood units. The project includes testing this protein...
This Project Grant award of $2,461,670.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports the development of ErythroMer (EM), a dried, bio-inspired artificial red blood cell substitute, by Kalocyte Inc., a biotech startup. The project aims to optimize the lyophilization and reconstitution of EM to improve its oxygen binding and release properties, as well as evaluate its efficacy, pharmacokinetics, dosing, and compatibility with...
The Department of the Army Medical Command awarded Cayuga Biotech Inc. a $922,870 Project Grant under the Military Medical Research and Development program (CFDA 12.420). The grant will support Cayuga Biotech's development of an intravenous agent for traumatic hemorrhage control from July 1, 2021 to June 30, 2022. The Military Medical Research and Development program aims to transform military and public health through innovative medical research solutions, including investigations into...
The Department of the Army Medical Command has awarded a $3,292,001 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to the Albert Einstein College of Medicine in Bronx, New York. The grant, effective June 1, 2025 through May 31, 2029, will fund the production of cultured red blood cells to support patients with sickle cell disease. The award leverages the college's expertise in biomedical research, clinical trials, and scientific investigations to...
The Department of the Army Medical Command awarded a $162,000 project grant to The Trustees of Columbia University in New York, NY under the Military Medical Research and Development program. The grant supports the development of amyloid fibril-specific chimeric antigen receptor macrophages (CAR-M)-based immunotherapy for amyloid clearance in light chain amyloidosis from August 1, 2021 through July 31, 2023. The Military Medical Research and Development program (CFDA 12.420) aims to conduct...
IHP Therapeutics Inc. was awarded a $217,928 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will support research from March 2022 through September 2023 to develop a novel glycan therapeutic to treat Acute Respiratory Distress Syndrome. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical research solutions. This award...
The U.S. Defense Health Agency awarded a $1,996,885 project grant under the Military Medical Research and Development program (CFDA 12.420) to Selsym Biotech Inc., a woman-owned small business. The funding supports the development of SYMCLOT, a synthetic platelet mimetic particle technology, to augment hemostasis for patients requiring extracorporeal support, such as those with battlefield injuries. Previous grants from the National Institutes of Health have also supported Selsym Biotech's...
The Department of the Army Medical Command awarded a $1,248,949 Project Grant to Massachusetts General Hospital through the Military Medical Research and Development program. The grant will fund research into stable mixed chimerism and tolerance of vascularized composite allografts via BCL-2 inhibition from September 30, 2022 to August 31, 2025. The Military Medical Research and Development program supports innovative biomedical research with the goals of improving military and public health...
The Department of the Army Medical Command awarded a $491,789 project grant to King's College London for developing Fas-resistant, bone marrow-tropic regulatory T cells (Tregs) for the treatment of immune aplastic anemia. The three-year project aligns with the Military Medical Research and Development program's goal of transforming health care through innovative medical research solutions. Specifically, the awardee will develop Tregs resistant to Fas-mediated apoptosis for targeting the bone...
The Massachusetts General Hospital was awarded a $999,792 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research into regulatory T-cell expansion and immune modulation in vascularized composite tissue transplants from September 15, 2021 through September 14, 2024. The Military Medical Research and Development program supports biomedical research that transforms military and public...